These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Endogenous glucocorticoid signalling in osteoblasts is necessary to maintain normal bone structure in mice. Kalak R; Zhou H; Street J; Day RE; Modzelewski JR; Spies CM; Liu PY; Li G; Dunstan CR; Seibel MJ Bone; 2009 Jul; 45(1):61-7. PubMed ID: 19358901 [TBL] [Abstract][Full Text] [Related]
3. Transgenic disruption of endogenous glucocorticoid signaling in osteoblasts does not alter long-term K/BxN serum transfer-induced arthritis. Maleitzke T; Wiebe E; Huscher D; Spies CM; Tu J; Gaber T; Zheng Y; Buttgereit F; Seibel MJ; Zhou H Arthritis Res Ther; 2023 Aug; 25(1):140. PubMed ID: 37542341 [TBL] [Abstract][Full Text] [Related]
4. Transgenic Disruption of Glucocorticoid Signaling in Osteoblasts Attenuates Joint Inflammation in Collagen Antibody-Induced Arthritis. Tu J; Zhang Y; Kim S; Wiebe E; Spies CM; Buttgereit F; Cooper MS; Seibel MJ; Zhou H Am J Pathol; 2016 May; 186(5):1293-301. PubMed ID: 26988651 [TBL] [Abstract][Full Text] [Related]
5. Lack of requirement of osteopontin for inflammation, bone erosion, and cartilage damage in the K/BxN model of autoantibody-mediated arthritis. Jacobs JP; Pettit AR; Shinohara ML; Jansson M; Cantor H; Gravallese EM; Mathis D; Benoist C Arthritis Rheum; 2004 Aug; 50(8):2685-94. PubMed ID: 15334485 [TBL] [Abstract][Full Text] [Related]
6. Acute murine antigen-induced arthritis is not affected by disruption of osteoblastic glucocorticoid signalling. Spies CM; Wiebe E; Tu J; Li A; Gaber T; Huscher D; Seibel MJ; Zhou H; Buttgereit F BMC Musculoskelet Disord; 2014 Feb; 15():31. PubMed ID: 24491163 [TBL] [Abstract][Full Text] [Related]
7. Impaired cortical bone acquisition and osteoblast differentiation in mice with osteoblast-targeted disruption of glucocorticoid signaling. Sher LB; Harrison JR; Adams DJ; Kream BE Calcif Tissue Int; 2006 Aug; 79(2):118-25. PubMed ID: 16927049 [TBL] [Abstract][Full Text] [Related]
8. R-spondin 1 protects against inflammatory bone damage during murine arthritis by modulating the Wnt pathway. Krönke G; Uderhardt S; Kim KA; Stock M; Scholtysek C; Zaiss MM; Surmann-Schmitt C; Luther J; Katzenbeisser J; David JP; Abdollahi-Roodsaz S; Tran K; Bright JM; Binnerts ME; Akhmetshina A; Böhm C; Distler JH; Joosten LA; Schett G; Abo A Arthritis Rheum; 2010 Aug; 62(8):2303-12. PubMed ID: 20506554 [TBL] [Abstract][Full Text] [Related]
9. Glucocorticoid-dependent Wnt signaling by mature osteoblasts is a key regulator of cranial skeletal development in mice. Zhou H; Mak W; Kalak R; Street J; Fong-Yee C; Zheng Y; Dunstan CR; Seibel MJ Development; 2009 Feb; 136(3):427-36. PubMed ID: 19141672 [TBL] [Abstract][Full Text] [Related]
10. The role of CD40 ligand and tumor necrosis factor alpha signaling in the transgenic K/BxN mouse model of rheumatoid arthritis. Kyburz D; Carson DA; Corr M Arthritis Rheum; 2000 Nov; 43(11):2571-7. PubMed ID: 11083282 [TBL] [Abstract][Full Text] [Related]
11. Endogenous glucocorticoid signaling in chondrocytes attenuates joint inflammation and damage. Tu J; Stoner S; Fromm PD; Wang T; Chen D; Tuckermann J; Cooper MS; Seibel MJ; Zhou H FASEB J; 2018 Jan; 32(1):478-487. PubMed ID: 28928247 [TBL] [Abstract][Full Text] [Related]
12. Transgenic expression of 11beta-hydroxysteroid dehydrogenase type 2 in osteoblasts reveals an anabolic role for endogenous glucocorticoids in bone. Sher LB; Woitge HW; Adams DJ; Gronowicz GA; Krozowski Z; Harrison JR; Kream BE Endocrinology; 2004 Feb; 145(2):922-9. PubMed ID: 14617568 [TBL] [Abstract][Full Text] [Related]
13. Chronic Mild Stress Causes Bone Loss via an Osteoblast-Specific Glucocorticoid-Dependent Mechanism. Henneicke H; Li J; Kim S; Gasparini SJ; Seibel MJ; Zhou H Endocrinology; 2017 Jun; 158(6):1939-1950. PubMed ID: 28368468 [TBL] [Abstract][Full Text] [Related]
14. A positive feedback loop of IL-21 signaling provoked by homeostatic CD4+CD25- T cell expansion is essential for the development of arthritis in autoimmune K/BxN mice. Jang E; Cho SH; Park H; Paik DJ; Kim JM; Youn J J Immunol; 2009 Apr; 182(8):4649-56. PubMed ID: 19342640 [TBL] [Abstract][Full Text] [Related]
15. Osteoblast-targeted disruption of glucocorticoid signalling does not delay intramembranous bone healing. Weber AJ; Li G; Kalak R; Street J; Buttgereit F; Dunstan CR; Seibel MJ; Zhou H Steroids; 2010 Mar; 75(3):282-6. PubMed ID: 20096296 [TBL] [Abstract][Full Text] [Related]
16. Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength. O'Brien CA; Jia D; Plotkin LI; Bellido T; Powers CC; Stewart SA; Manolagas SC; Weinstein RS Endocrinology; 2004 Apr; 145(4):1835-41. PubMed ID: 14691012 [TBL] [Abstract][Full Text] [Related]
17. Osteoblast-targeted expression of Sfrp4 in mice results in low bone mass. Nakanishi R; Akiyama H; Kimura H; Otsuki B; Shimizu M; Tsuboyama T; Nakamura T J Bone Miner Res; 2008 Feb; 23(2):271-7. PubMed ID: 17907918 [TBL] [Abstract][Full Text] [Related]
18. Bone marrow-derived cells are responsible for the development of autoimmune arthritis in human T cell leukemia virus type I-transgenic mice and those of normal mice can suppress the disease. Saijo S; Kotani M; Habu K; Ishitsuka C; Yamamoto H; Sekiguchi T; Iwakura Y J Immunol; 1999 Nov; 163(10):5700-7. PubMed ID: 10553101 [TBL] [Abstract][Full Text] [Related]
19. Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia. Li J; Sarosi I; Cattley RC; Pretorius J; Asuncion F; Grisanti M; Morony S; Adamu S; Geng Z; Qiu W; Kostenuik P; Lacey DL; Simonet WS; Bolon B; Qian X; Shalhoub V; Ominsky MS; Zhu Ke H; Li X; Richards WG Bone; 2006 Oct; 39(4):754-66. PubMed ID: 16730481 [TBL] [Abstract][Full Text] [Related]
20. Blocking glucocorticoid signaling in osteoblasts and osteocytes prevents mechanical unloading-induced cortical bone loss. Yang J; Li J; Cui X; Li W; Xue Y; Shang P; Zhang H Bone; 2020 Jan; 130():115108. PubMed ID: 31704341 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]